Nano-X Imaging (NASDAQ:NNOX) Earns “Buy” Rating from D. Boral Capital

Nano-X Imaging (NASDAQ:NNOX)‘s stock had its “buy” rating restated by equities researchers at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They currently have a $5.00 target price on the stock. D. Boral Capital’s price target suggests a potential upside of 88.68% from the stock’s current price.

A number of other research analysts have also weighed in on the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Nano-X Imaging in a report on Monday, December 29th. LADENBURG THALM/SH SH upgraded shares of Nano-X Imaging to a “strong-buy” rating in a research report on Thursday, November 20th. Two equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $7.00.

Nano-X Imaging Stock Performance

Shares of Nano-X Imaging stock opened at $2.65 on Tuesday. The stock’s 50-day simple moving average is $2.72 and its 200 day simple moving average is $3.39. Nano-X Imaging has a 52-week low of $2.11 and a 52-week high of $6.42. The stock has a market capitalization of $173.26 million, a P/E ratio of -2.01 and a beta of 1.38.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Weiss Asset Management LP purchased a new stake in shares of Nano-X Imaging in the 4th quarter worth approximately $8,424,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Nano-X Imaging by 232.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,160,806 shares of the company’s stock worth $10,793,000 after purchasing an additional 1,510,806 shares during the period. UBS Group AG boosted its position in Nano-X Imaging by 40.8% in the fourth quarter. UBS Group AG now owns 1,530,104 shares of the company’s stock worth $4,284,000 after purchasing an additional 443,459 shares during the last quarter. Jane Street Group LLC increased its holdings in Nano-X Imaging by 4,646.0% during the fourth quarter. Jane Street Group LLC now owns 206,073 shares of the company’s stock valued at $577,000 after buying an additional 201,731 shares during the last quarter. Finally, ARK Investment Management LLC lifted its position in Nano-X Imaging by 31.9% during the fourth quarter. ARK Investment Management LLC now owns 507,421 shares of the company’s stock valued at $1,421,000 after purchasing an additional 122,633 shares in the last quarter. 21.49% of the stock is owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.